Safeguard Scientifics, Inc. (NYSE:SFE) – Stock analysts at First Analysis issued their Q2 2018 earnings per share (EPS) estimates for Safeguard Scientifics in a research report issued on Friday. First Analysis analyst J. Macdonald expects that the asset manager will post earnings of ($1.09) per share for the quarter.

Safeguard Scientifics (NYSE:SFE) last issued its quarterly earnings results on Thursday, July 27th. The asset manager reported ($1.43) earnings per share for the quarter, missing the consensus estimate of ($1.11) by $0.32. During the same quarter in the previous year, the company posted $1.92 earnings per share.

ILLEGAL ACTIVITY NOTICE: “Safeguard Scientifics, Inc. to Post Q2 2018 Earnings of ($1.09) Per Share, First Analysis Forecasts (SFE)” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/08/10/safeguard-scientifics-inc-to-post-q2-2018-earnings-of-1-09-per-share-first-analysis-forecasts-sfe-updated.html.

Other research analysts have also issued reports about the company. BidaskClub raised Safeguard Scientifics from a “hold” rating to a “buy” rating in a research report on Thursday, July 13th. Zacks Investment Research lowered Safeguard Scientifics from a “buy” rating to a “hold” rating in a research report on Thursday, May 4th. Finally, ValuEngine raised Safeguard Scientifics from a “strong sell” rating to a “sell” rating in a research report on Friday, June 2nd.

Safeguard Scientifics (NYSE:SFE) opened at 11.85 on Monday. Safeguard Scientifics has a one year low of $10.60 and a one year high of $14.38. The stock’s 50 day moving average price is $11.92 and its 200 day moving average price is $12.15. The company’s market capitalization is $241.89 million.

A number of hedge funds and other institutional investors have recently made changes to their positions in SFE. Wells Fargo & Company MN raised its position in shares of Safeguard Scientifics by 5.2% in the first quarter. Wells Fargo & Company MN now owns 15,951 shares of the asset manager’s stock valued at $203,000 after buying an additional 791 shares in the last quarter. American International Group Inc. raised its position in shares of Safeguard Scientifics by 7.2% in the first quarter. American International Group Inc. now owns 12,407 shares of the asset manager’s stock valued at $158,000 after buying an additional 833 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of Safeguard Scientifics by 12.9% in the first quarter. Goldman Sachs Group Inc. now owns 15,336 shares of the asset manager’s stock valued at $195,000 after buying an additional 1,754 shares in the last quarter. Bank of America Corp DE raised its position in shares of Safeguard Scientifics by 8.2% in the first quarter. Bank of America Corp DE now owns 25,289 shares of the asset manager’s stock valued at $321,000 after buying an additional 1,907 shares in the last quarter. Finally, Bank of New York Mellon Corp raised its position in shares of Safeguard Scientifics by 2.8% in the first quarter. Bank of New York Mellon Corp now owns 101,350 shares of the asset manager’s stock valued at $1,288,000 after buying an additional 2,774 shares in the last quarter. 76.96% of the stock is currently owned by institutional investors.

About Safeguard Scientifics

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Receive News & Stock Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related stocks with our FREE daily email newsletter.